IBEX (NASDAQ: IBEX) releases fiscal Q2 results for quarter ended Dec 31, 2025

Rhea-AI Filing Summary

IBEX Limited filed a current report to share that it has released financial results for its second fiscal quarter ended December 31, 2025. On February 5, 2026, the company issued a press release detailing these quarterly results, which is included as Exhibit 99.1. The report notes that this earnings information is being furnished rather than filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.

FALSE000172042000017204202026-02-052026-02-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________________________________________________

FORM 8-K

____________________________________________________________

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 5, 2026

____________________________________________________________

IBEX Limited

(Exact name of registrant as specified in its charter)

____________________________________________________________

Bermuda			001-38442			00-0000000
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)

1717 Pennsylvania Avenue NW, Suite 825

Washington, District of Columbia 20006

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (202) 580-6200

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class			Trading Symbol(s)			Name of Each Exchange on Which Registered
Common shares, par value of $0.000111650536			IBEX			Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company               x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.               o

Item 2.02. Results of Operations and Financial Condition.

On February 5, 2026, IBEX Limited issued a press release announcing its financial results for its second fiscal quarter ended December 31, 2025.

A copy of the February 5, 2026 press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.

The information in this Item 2.02, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

EXHIBIT INDEX

Exhibit No.         Description

99.1         Press release announcing financial results for the second fiscal quarter ended December 31, 2025,

dated February 5, 2026

104         Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			IBEX LIMITED
			(Registrant)
Date: February 5, 2026			/s/ Taylor Greenwald
			(Signature)
			Name:			Taylor Greenwald
			Title:			Chief Financial Officer

FAQ

What did IBEX (IBEX) disclose in this 8-K filing?

IBEX disclosed that it issued a press release with financial results for its second fiscal quarter ended December 31, 2025. The 8-K furnishes this earnings release as Exhibit 99.1 for investors and analysts to review.

Which period do IBEX (IBEX)'s latest reported results cover?

The reported results cover IBEX’s second fiscal quarter ended December 31, 2025. The company indicated in the filing that a detailed press release for this period is attached as Exhibit 99.1 to the current report.

When did IBEX (IBEX) issue its second quarter fiscal 2025 results press release?

IBEX issued its press release on February 5, 2026. The filing states that this release, announcing financial results for the second fiscal quarter ended December 31, 2025, is furnished as Exhibit 99.1 to the current report.

Where can investors find the detailed IBEX (IBEX) quarterly financial results?

Investors can find the detailed quarterly results in the press release attached as Exhibit 99.1. The current report explains that this exhibit contains IBEX’s financial results for the second fiscal quarter ended December 31, 2025.

Are IBEX (IBEX)'s quarterly results deemed filed or furnished?

The quarterly results are being furnished, not filed. The company specifies that the information in Item 2.02 and the related exhibits are furnished under the Exchange Act and are not automatically incorporated into other securities law filings.

Who signed IBEX (IBEX)'s 8-K for the quarterly results release?

The 8-K was signed on behalf of IBEX Limited by Taylor Greenwald. The filing identifies Taylor Greenwald as the company’s Chief Financial Officer, serving as the duly authorized officer for this report.